Next Article in Journal
Driver Attention Area Extraction Method Based on Deep Network Feature Visualization
Previous Article in Journal
Development of Energy-Based Impact Formula-Part II: Scabbing Depth, Scabbing Limit, and Perforation Limit
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Validation of a HPLC–PDA Method for the Simultaneous Determination of Berberine, Palmatine, Geniposide, and Paeoniflorin in Haedoksamul-tang

1
College of Pharmacy, Pusan National University, Busan 46241, Korea
2
Department of Physiology, College of Korean Medicine, Dongeui University, Busan 47227, Korea
*
Authors to whom correspondence should be addressed.
Appl. Sci. 2020, 10(16), 5482; https://doi.org/10.3390/app10165482
Submission received: 11 July 2020 / Revised: 30 July 2020 / Accepted: 6 August 2020 / Published: 7 August 2020

Abstract

:
Haedoksamul-tang (HST) is a traditional medical prescription comprising eight medicinal herbs: Angelica gigas, Cnidium officinale, Coptis japonica, Gardenia jasminoides, Paeonia lactiflora, Phellodendron amurense, Rehmannia glutinosa, and Scutellaria baicalensis. HST is used to treat blood circulation disorders and has anti-inflammatory, hemostatic, and anticonvulsant effects. In this study, a high-performance liquid chromatography/photodiode array detector (HPLC–PDA) method was developed and validated for the simultaneous determination of four marker compounds in HST, namely, berberine, palmatine, geniposide, and paeoniflorin. Four standard solutions and HST sample solutions were analyzed using a reverse-phase SunFire®C18 column (4.6 × 250 mm, 5 μm) using a 0.05% aqueous formic acid/methanol gradient. The column temperature, flow rate, injection volume, and wavelengths used were 28 ± 2 ℃, 1.0 mL/min, 10.0 μL, and 230 nm and 240 nm, respectively. Calibration curves of the four marker compounds showed good linearity (r2 ≥ 0.9994), and limits of detection (LODs) and quantification (LOQs) were in the ranges 0.131–0.296 μg/mL and 0.398–0.898 μg/mL, respectively. Ranges of intra- and inter-day precisions and accuracies values were 96.74–102.53% and 97.95–100.83%, respectively, and relative standard deviation (RSD) values were all <4%. Recoveries averaged 92.33–116.72% with RSD values <5%. Quantitative analysis for the four marker compounds showed geniposide (10.77 mg/g) was most abundant in HST.

1. Introduction

Haedoksamul-tang (HST), also known as Onchungeum in Korea, Wen-Qing-Yin in China, and Unsei-in in Japan, is a traditional medical prescription comprising Hwangryunhaedok-tang (HHT) and Samul-tang (SMT). According to the Donguibogam (principles and practice of eastern medicine), HST has been traditionally used to treat abnormal uterine bleeding and abdominal pain in women or to treat flooding accompanied by a yellowish complexion, stomach aches, and alternating chills [1]. According to several studies, HST exhibits diverse therapeutic effects on inflammation [2,3,4,5,6,7], atopic dermatitis [8,9,10,11], blood stasis [12,13], Behcet’s syndrome [14,15], hyperlipidemia [16], and oxidative stress [17,18,19,20].
HST consists of eight medicinal herbs: Angelica gigas (Apiaceae), Cnidium officinale (Umbelliferae), Coptis japonica (Ranunculaceae), Gardenia jasminoides (Rubiaceae), Paeonia lactiflora (Paeoniaceae), Phellodendron amurense (Rutaceae), Rehmannia glutinosa (Orobanchaceae), and Scutellaria baicalensis (Lamiaceae). The major components of the eight medicinal herbs in HST are: flavones (e.g., baicalin, wogonin, and baicalein) from Scutellaria baicalensis [21], alkaloids (e.g., berberine, palmatine, coptisine, jatrorrhizine, and epiberberine) from Coptis japonica [22], alkaloids (e.g., palmatine, phellodendrine, magnoflorine, and berberine) from Phellodendron amurense [23], iridoids (e.g., geniposide, genipin, genipin-1-β gentiobioside, and geniposidic acid) from Gardenia jasminoides [24], iridoids (e.g., catalpol) from Rehmannia glutinosa [25], coumarins (e.g., decursin, decursinol, decursinol angelate, and nodakenin) from Angelica gigas [26], monoterpenoids (e.g., paeoniflorin, albiflorin, benzoylpaeoniflorin, and oxypaeoniflorin) and phenols (e.g., paeonol and (+)-catechin) from Paeonia lactiflora [27], and phthalides (e.g., senkyunolideA, Z-ligustilide, and Z-butylidenephthalide) and ferulic acid from Cnidium officinale [28]. Qualitative and quantitative analyses of HHT and SMT by high-performance liquid chromatography (HPLC) using photodiode array (PDA) detectors have been previously reported [29,30,31,32]. Recently, a method for simultaneous quantification of six biomarkers (berberine, baicalin, ferulic acid, geniposide, hydorxymethoxylfurfural, and paeoniflorin) in HST by high-performance liquid chromatography/diode array detector (HPLC-DAD) was developed [33]. However, analysis results depended on geographic sources and cultivation environments, and the analysis data was inadequate for standardizing HST quality. In the present study, we devised and validated a HPLC-PDA method for the simultaneous determination of four biomarkers in HST (berberine from Coptis japonica, palmatine from Phellodendron amurense, geniposide from Gardenia jasminoides, paeoniflorin from Paeonia lactiflora).

2. Materials and Methods

2.1. Plant Materials and Chemicals

Scutellaria baicalensis was purchased from Hyunjin pharmaceutical Corp., Coptis japonica from Miryung herb medicine Ltd., Gardenia jasminoides, Phellodendron amurense, and Rehmannia glutinosa from Taechang pharmaceutical Corp., Angelica gigas, Cnidium officinale, and Paeonia lactiflora from Jechen traditional herbal market. All herbal materials were authenticated by Professor Eun Ju Jeong of the Department of Agronomy and Medicinal Plant Resources at Gyeongnam National University of Science and Technology (Jinju, South Korea). Voucher specimens (PNU-0028~PNU-0035) were deposited at the College of Pharmacy, Pusan National University.
Geniposide was isolated from G. jasminoides by column chromatography in our laboratory and used as a reference standard. The structure of geniposide was determined by nuclear magnetic resonance (NMR) [34], and their purities by HPLC (≥98.0%). Other reference standards: berberine (≥98.0%), palmatine (≥98.0%), and paeoniflorin (≥98.0%) were purchased from ChemFaces Biochemical Co., Ltd. (Wuhan, China). Water, acetonitrile, methanol (Honeywell Burdick and Jackson, Muskegon, MI, USA), and formic acid (DAEJUNG Chemicals & Metals Co., Ltd., Siheung-si, Korea) were of HPLC grade.

2.2. Preparation of Haedoksamul-Tang (HST) Extract

The eight herbal materials (100 g of each) were mixed and crushed for HST extraction, and then extracted for 3 h in 8 L of distilled water using an ultrasonic extractor. The extract was passed through filter paper (Advantec, Tokyo, Japan), concentrated under vacuum at 50 °C, and freeze-dried. The lyophilized HST extract was sieved to a particle size of <0.425 mm with a standard sieve and 117.6 g of HST (hereafter referred to as HST) was obtained (yield, 14.7%).

2.3. Preparation of Samples and Standard Solutions

Sample solutions contained HST (40.0 mg) dissolved in distilled water at a concentration of 20.0 mg/mL, and then sonicated for 10 min at room temperature and filtered through a 0.5 μm polytetrafluoroethylene (PTFE) syringe filter (13JP050AN, Advantec, Tokyo, Japan) prior to injection.
Standard stock solutions of the four reference standards (Figure 1), berberine, palmatine, geniposide, and paeoniflorin, were prepared at concentrations of 500.0 μg/mL, 500.0 μg/mL, 1000.0 μg/mL, and 1000.0 μg/mL, respectively, in methanol. All solutions were stored in a refrigerator at 4 °C until required for analysis.

2.4. High-Performance Liquid Chromatography–Photodiode Array (HPLC–PDA) Equipment and Chromatographic Conditions

Simultaneous analysis of the berberine, palmatine, geniposide, and paeoniflorin in HST was performed using a Waters Alliance system (Waters Corporation, Milford, MA 01757, USA) consisting of an e 2695 separation module and a 2998 photodiode array (PDA) detector. All chromatographic data were recorded and analyzed using Empower three chromatography data software. The four components were separated using a reverse-phase SunFire® C18 column (100 Å, 4.6 × 250 mm ID, 5 μm particle size, Waters), which was maintained at 28 ± 2 ℃. The mobile phase consisted of 0.05% (v/v) formic acid in water (A) and methanol (B); solvents were degassed prior to analysis. The optimum gradient elution system used was as follows: 0–30 min, 10–50% (B); 30–35 min, 50–90% (B); 35–45 min, 90–90% (B); and 45–46 min, 90–10% (B). The flow rate and injection volume used were 1.0 mL/min and 10.0 μL, and detection wavelengths for quantification and analysis were set at 230 nm and 240 nm.

2.5. Method Validation

The HPLC analytical method devised was evaluated by determining its specificity, linearity, limit of detection (LOD), limit of quantitation (LOQ), precision, and recovery performance as detailed by the International Conference on Harmonisation (ICH) guidelines [35].

2.5.1. Specificity

The specificity was determined by comparing chromatograms and PDA spectral patterns (λ = 200–400 nm) obtained from standard mixtures and HST samples.

2.5.2. Linearity, Limit of Detection (LOD), and Limit of Quantitation (LOQ)

Calibration curves of berberine, palmatine, geniposide, and paeoniflorin stock solutions were plotted over the concentration ranges 2.50–25.00 μg/mL, 2.50–25.00 μg/mL, 2.50–25.00 μg/mL, and 2.50–25.00 μg/mL, respectively. Solutions were analyzed in quintuplicate, and calibration curves were obtained by plotting peak areas (Y) versus compound concentrations (x, μg/mL). Correlation coefficients (r2) obtained from calibration curves were used to evaluate linearity, and all r2 values exceeded 0.999. LOD and LOQ were calculated using the standard deviations of y-intercepts (σ) and calibration curve slopes (S), as follows:
LOD = 3.3   ×   σ S
LOQ = 10   ×   σ S

2.5.3. Precision

The precision of the developed method was determined by inter-day and intra-day testing at three different concentrations. Intra-day precision was measured by performing analyses three times per day, and inter-day precision was measured by repeating analyses three times per day over three consecutive days. Precisions were determined by calculating relative standard deviation (RSD) using:
RSD   ( % ) = standard   deviation   ( SD ) mean   measured   amount × 100

2.5.4. Recovery

Recovery testing was performed to verify the accuracy of the optimized HPLC–PDA method. Recovery was evaluated by spiking standard solution and HST samples with different amounts of berberine, palmatine, geniposide, and paeoniflorin. All analyses were performed in triplicate. Recovery was calculated as follows:
Recovery   ( % ) = ( found   amount original   amount ) spiked   amount × 100

3. Results and Discussion

3.1. Optimization of HPLC–PDA Conditions

Optimal HPLC–PDA conditions were obtained by optimizing column type, column temperature, and mobile phase variables. For efficient separation of peaks, a SunFire® C18 column (5 µm, 100 Å, 4.6 mm × 250 mm, Waters) was used at a column temperature of 28 ± 2 ℃ with a water (0.05% formic acid)/methanol gradient elution system. The maximum ultraviolet (UV) absorption wavelengths of the four components were confirmed using PDA UV spectra (λ = 200–400 nm), and wavelengths of 230, 230, 240, and 230 nm were selected for berberine, palmatine, geniposide, and paeoniflorin, respectively (Figure 2).

3.2. Method Validation

3.2.1. Specificity

Method specificity was evaluated by comparing retention time and UV spectra of standard mixtures and HST samples. Comparisons showed retention times and UV absorbances of HST samples and the four reference standards were well matched (Figure 3). The wavelengths used for analysis were as follows; berberine (λmax = 228.3, 263.8, and 346.2 nm), palmatine (λmax = 226.0, 273.3, and 343.8 nm), geniposide (λmax = 239.0 nm), and paeoniflorin (λmax = 231.9 and 274.5 nm).

3.2.2. Linearity, LOD and LOQ

HPLC–PDA linearity results for berberine, palmatine, geniposide and paeoniflorin showed excellent linearity (r2 ≥ 0.9994) in the concentration range 2.50–25.00 μg/mL for berberine and palmatine and 5.00–50.00 μg/mL of geniposide and paeoniflorin. The LOD and LOQ values of the four compounds ranged from 0.131–0.296 μg/mL and 0.398–0.898 μg/mL, respectively (Table 1).

3.2.3. Precision

Precision was determined by intra-day and inter-day analysis. The intra-day and inter-day RSDs of the four compounds ranged from 0.111% to 2.857% and from 0.946% to 3.593%, respectively. Accuracy values ranged from 96.74% to 102.53% and from 97.95% to 100.83%, respectively (Table 2). The intra-day and inter-day RSDs of berberine, palmatine, geniposide, and paeoniflorin were all <4%. Thus, the developed method was found to be both reliable and reproducible.

3.2.4. Recovery

Recovery testing was performed in triplicate using the method developed by spiking HST samples with reference standards. The average recoveries of berberine, palmatine, geniposide, and paeoniflorin ranged from 92.33% to 116.72% and RSD values from 0.731% to 4.705% (Table 3). Therefore, the developed assay method was found to be suitable for analyzing levels of the four compounds in HST samples.

3.3. Quantitative Analysis of Four Marker Compounds in HST

The HPLC–PDA based method showed that HST contained 2.11 mg/g of berberine, 1.54 mg/g of palmatine, 10.77 mg/g of geniposide, and 7.04 mg/g paeoniflorin, and all RSD values were <3% (Table 4). In other words, geniposide, the major compound in Gardenia jasminoides, was the most abundant, followed by paeoniflorin, the major compound in Paeonia lactiflora.

4. Conclusions

Summarizing, we developed and verified a HPLC–PDA-based analytical method for the simultaneous determination of berberine, palmatine, geniposide, and paeoniflorin in HST. The optimized method utilized a 0.05% formic acid in water/methanol gradient elution system and a reverse-phase C18 column. Validation of the optimized analytical method was performed by determining specificities, linearities, limits of detection (LODs), and limits of quantification (LOQs) and using precision and recovery tests. In addition, we confirmed that geniposide (the marker compound of Gardenia jasminoides) is abundant in HST. We hope that the method developed and data acquired during the course of this study will be found useful for efficient quality control and standardization of HST.

Author Contributions

Conceptualization, K.-H.K. and M.H.Y.; performing experiments and analyzing data, B.-G.J.; Writing—Original draft preparation, B.-G.J. and M.H.Y.; funding acquisition, K.-H.K. and M.H.Y. All authors read and agreed to the published version of the manuscript.

Funding

This research was supported by the National Research Foundation of Korea (NRF) funded by the Korean government (Grant no. NRF-2018R1A2A3075248).

Conflicts of Interest

The authors have no conflict of interest to declare.

References

  1. Heo, J. Donguibogam Internal Bodily Elements (Type C), 1st ed.; Humanist: Seoul, Korea, 2002; p. 1394, 1396, 1398, 1420. [Google Scholar]
  2. Zeng, H.; Liu, X.; Dou, S.; Xu, W.; Li, N.; Liu, X.; Zhang, W.; Hu, Z.; Liu, R. Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. J. Pharm. Pharmacol. 2009, 61, 1699–1707. [Google Scholar] [CrossRef] [PubMed]
  3. Dai, Y.; But, P.P.-H.; Chan, Y.-P.; Matsuda, H.; Kubo, M. Antipruritic and antiinflammatory effects of aqueous extract from Si-Wu-Tang. Biol. Pharm. Bull. 2002, 25, 1175–1178. [Google Scholar] [CrossRef] [Green Version]
  4. Chen, H.-B.; Luo, C.-D.; Liang, J.-L.; Zhang, Z.-B.; Lin, G.-S.; Wu, J.-Z.; Li, C.-L.; Tan, L.-H.; Yang, X.-B.; Su, Z.-R. Anti-inflammatory activity of coptisine free base in mice through inhibition of NF-κB and MAPK signaling pathways. Eur. J. Pharmacol. 2017, 811, 222–231. [Google Scholar] [CrossRef]
  5. Yan, B.; Wang, D.; Dong, S.; Cheng, Z.; Na, L.; Sang, M.; Yang, H.; Yang, Z.; Zhang, S.; Yan, Z. Palmatine inhibits TRIF-dependent NF-κB pathway against inflammation induced by LPS in goat endometrial epithelial cells. Int. Immunopharmacol. 2017, 45, 194–200. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Pan, T.; Shi, X.; Chen, H.; Chen, R.; Wu, D.; Lin, Z.; Zhang, J.; Pan, J. Geniposide suppresses interleukin-1β-induced inflammation and apoptosis in rat chondrocytes via the PI3K/Akt/NF-κB signaling pathway. Inflammation 2018, 41, 390–399. [Google Scholar] [CrossRef] [PubMed]
  7. Xin, Q.; Yuan, R.; Shi, W.; Zhu, Z.; Wang, Y.; Cong, W. A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders. Life Sci. 2019, 237, 116925. [Google Scholar] [CrossRef]
  8. Andoh, T.; Al-Akeel, A.; Tsujii, K.; Nojima, H.; Kuraishi, Y. Repeated treatment with the traditional medicine Unsei-in inhibits substance P-induced itch-associated responses through downregulation of the expression of nitric oxide synthase 1 in mice. J. Pharmacol. Sci. 2004, 94, 207–210. [Google Scholar] [CrossRef] [Green Version]
  9. Andoh, T.; Honma, Y.; Kawaharada, S.; Al-Akeel, A.; Nojima, H.; Kuraishi, Y. Inhibitory effect of the repeated treatment with Unsei-in on substance P-induced itch-associated responses through the downregulation of the expression of NK1 tachykinin receptor in mice. Biol. Pharm. Bull. 2003, 26, 896–898. [Google Scholar] [CrossRef] [Green Version]
  10. Li, Y.; Xie, J.; Li, Y.; Yang, Y.; Yang, L. Literature data based systems pharmacology uncovers the essence of “body fire” in traditional Chinese medicine: A case by Huang-Lian-Jie-Du-Tang. J. Ethnopharmacol. 2019, 237, 266–285. [Google Scholar] [CrossRef]
  11. Chen, Y.; Xian, Y.; Lai, Z.; Loo, S.; Chan, W.Y.; Lin, Z.-X. Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: Implication for atopic dermatitis treatment. J. Ethnopharmacol. 2016, 185, 41–52. [Google Scholar] [CrossRef]
  12. Tanabe, H.; Suzuki, H.; Nagatsu, A.; Mizukami, H.; Ogihara, Y.; Inoue, M. Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in. Phytomedicine 2006, 13, 334–342. [Google Scholar] [CrossRef] [PubMed]
  13. Lee, Y.M.; Kim, C.-S.; Jo, K.; Sohn, E.J.; Kim, J.S.; Kim, J. Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy. BMC Complement. Altern. Med. 2015, 15, 1–7. [Google Scholar] [CrossRef] [Green Version]
  14. Ono, Y. Immunopharmacological studies of Unsei-in (Wen-Qing-Yin), a chinese blended medicine: Examination of most effective one of chinese herbs composed of Unsei-in on type IV hypersensitivity reaction. J. Med. Pharm. Soc. WAKAN-YAKU 1988, 5, 68–73. [Google Scholar]
  15. Koda, A.; Ono, Y.; Nishiyori, T.; Nagai, H.; Matsuura, N.; Mase, A.; Matsuyama, T. Immunopharmacological studies of Wen-Qing-Yin, a Chinese blended medicine: Effects of type IV allergic reactions and humoral antibody production. Int. J. Immunopharmacol. 1987, 9, 289–295. [Google Scholar] [CrossRef]
  16. Choi, G.H.; Jung, Y.S.; Shin, H.C.; Choi, G.H.; Jung, Y.S.; Shin, H.C. The effects of haedoksamul-tang on oxidative stress and hyperlipidemia in LPS-induced ICR mouse. J. Korean Med. 2016, 37, 77–89. [Google Scholar] [CrossRef] [Green Version]
  17. Liu, M.; Ravula, R.; Wang, Z.; Zuo, Z.; Chow, M.S.; Thakkar, A.; Prabhu, S.; Andresen, B.; Huang, Y. Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes. Cell Biosci. 2014, 4, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Ohta, Y.; Kongo-Nishimura, M.; Hayashi, T.; Kishikawa, T. Effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. J. Ethnopharmacol. 2004, 94, 323–329. [Google Scholar] [CrossRef]
  19. Pan, L.; Zhou, J.; Zhu, H.; Wang, W.; Zhang, M.; Tian, X.; Lu, J.; Zeng, M. Study on integrated pharmacokinetics of gardenia acid and geniposide: Time-antioxidant efficacy after oral administration of Huanglian-Zhizi couplet medicine from Huang-Lian-Jie-Du-Tang in MCAO rats. Am. J. Chin. Med. 2014, 42, 393–407. [Google Scholar] [CrossRef]
  20. Chiu, H.F.; Wu, Y.H.; Shen, Y.C.; Wang, S.J.; Venkatakrishnan, K.; Wang, C.K. Antioxidant and physiological effects of Si-Wu-Tang on skin and liver: A randomized, double-blind, placebo-controlled clinical trial. Chin. Med. 2016, 11, 30. [Google Scholar] [CrossRef] [Green Version]
  21. Yu, K.; Gong, Y.; Lin, Z.; Cheng, Y. Quantitative analysis and chromatographic fingerprinting for the quality evaluation of Scutellaria baicalensis Georgi using capillary electrophoresis. J. Pharm. Biomed. Anal. 2007, 43, 540–548. [Google Scholar] [CrossRef]
  22. Li, J.-Y.; Wang, X.-B.; Luo, J.-G.; Kong, L.-Y. Seasonal variation of alkaloid contents and anti-inflammatory activity of Rhizoma coptidis based on fingerprints combined with chemometrics methods. J. Chromatogr. Sci. 2015, 53, 1131–1139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Xian, X.; Sun, B.; Ye, X.; Zhang, G.; Hou, P.; Gao, H. Identification and analysis of alkaloids in cortex Phellodendron amurense by high-performance liquid chromatography with electrospray ionization mass spectrometry coupled with photodiode array detection. J. Sep. Sci. 2014, 37, 1533–1545. [Google Scholar] [CrossRef] [PubMed]
  24. Wu, X.; Zhou, Y.; Yin, F.; Mao, C.; Li, L.; Cai, B.; Lu, T. Quality control and producing areas differentiation of Gardeniae Fructus for eight bioactive constituents by HPLC–DAD–ESI/MS. Phytomedicine 2014, 21, 551–559. [Google Scholar] [CrossRef] [PubMed]
  25. Li, S.-L.; Song, J.-Z.; Qiao, C.-F.; Zhou, Y.; Qian, K.; Lee, K.-H.; Xu, H.-X. A novel strategy to rapidly explore potential chemical markers for the discrimination between raw and processed Radix Rehmanniae by UHPLC–TOFMS with multivariate statistical analysis. J. Pharm. Biomed. Anal. 2010, 51, 812–823. [Google Scholar] [CrossRef] [PubMed]
  26. Jeong, S.Y.; Kim, H.M.; Lee, K.H.; Kim, K.Y.; Huang, D.S.; Kim, J.H.; Seong, R.S. Quantitative analysis of marker compounds in Angelica gigas, Angelica sinensis, and Angelica acutiloba by HPLC/DAD. Chem. Pharm. Bull. 2015, 63, 504–511. [Google Scholar] [CrossRef] [Green Version]
  27. Xu, S.; Yang, L.; Tian, R.; Wang, Z.; Liu, Z.; Xie, P.; Feng, Q. Species differentiation and quality assessment of Radix Paeoniae Rubra (Chi-shao) by means of high-performance liquid chromatographic fingerprint. J. Chromatogr. A 2009, 1216, 2163–2168. [Google Scholar] [CrossRef]
  28. Yi, T.; Leung, K.S.-Y.; Lu, G.-H.; Chan, K.; Zhang, H. Simultaneous qualitative and quantitative analyses of the major constituents in the rhizome of Ligusticum chuanxiong using HPLC-DAD-MS. Chem. Pharm. Bull. 2006, 54, 255–259. [Google Scholar] [CrossRef] [Green Version]
  29. Seo, C.-S.; Kim, O.S.; Kim, J.-H.; Shin, H.-K. Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang. BMC Complement. Altern. Med. 2015, 15, 108. [Google Scholar] [CrossRef] [Green Version]
  30. Kwok, K.Y.; Xu, J.; Ho, H.M.; Chen, H.B.; Li, M.; Lang, Y.; Han, Q.B. Quality evaluation of commercial Huang-Lian-Jie-Du-Tang based on simultaneous determination of fourteen major chemical constituents using high performance liquid chromatography. J. Pharm. Biomed. Anal. 2013, 85, 239–244. [Google Scholar] [CrossRef] [Green Version]
  31. Zhang, H.; Shen, P.; Cheng, Y. Identification and determination of the major constituents in traditional Chinese medicine Si-Wu-Tang by HPLC coupled with DAD and ESI–MS. J. Pharm. Biomed. Anal. 2004, 34, 705–713. [Google Scholar] [CrossRef]
  32. Wang, Z.-J.; Wo, S.-K.; Wang, L.; Lau, C.B.S.; Lee, V.H.L.; Chow, M.S.S.; Zuo, Z. Simultaneous quantification of active components in the herbs and products of Si-Wu-Tang by high performance liquid chromatography–mass spectrometry. J. Pharm. Biomed. Anal. 2009, 50, 232–244. [Google Scholar] [CrossRef] [PubMed]
  33. Yeh, C.-C.; Huang, S.-S.; Liu, P.-Y.; Wang, B.-C.; Tsai, C.-F.; Wang, D.-Y.; Cheng, H.-F. Simultaneous quantification of six indicator compounds in Wen-Qing-Yin by high-performance liquid chromatography-diode array detection. J. Food Drug Anal. 2019, 27, 749–757. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Zhou, T.; Fan, G.; Hong, Z.; Chai, Y.; Wu, Y. Large-scale isolation and purification of geniposide from the fruit of Gardenia jasminoides Ellis by high-speed counter-current chromatography. J. Chromatogr. A 2005, 1100, 76–80. [Google Scholar] [CrossRef]
  35. International Council for Harmonisation (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R1). In Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1 November 2005. [Google Scholar]
Figure 1. Chemical structures of standard compounds.
Figure 1. Chemical structures of standard compounds.
Applsci 10 05482 g001
Figure 2. High-performance liquid chromatography (HPLC) chromatograms of standard mixtures (A) and a Haedoksamul-tang (HST) sample (B). (1), berberine; (2), palmatine; (3), geniposide; (4), paeoniflorin.
Figure 2. High-performance liquid chromatography (HPLC) chromatograms of standard mixtures (A) and a Haedoksamul-tang (HST) sample (B). (1), berberine; (2), palmatine; (3), geniposide; (4), paeoniflorin.
Applsci 10 05482 g002
Figure 3. Photodiode array (PDA) detector spectra of the 4 reference standards (AD) and of a HST extract (A′–D′). (A), berberine; (B), palmatine; (C), geniposide; (D), paeoniflorin.
Figure 3. Photodiode array (PDA) detector spectra of the 4 reference standards (AD) and of a HST extract (A′–D′). (A), berberine; (B), palmatine; (C), geniposide; (D), paeoniflorin.
Applsci 10 05482 g003
Table 1. Retention times, linear range, calibration curves, limits of detection (LODs), and limits of quantitation (LOQs) of the four compounds (n = 5).
Table 1. Retention times, linear range, calibration curves, limits of detection (LODs), and limits of quantitation (LOQs) of the four compounds (n = 5).
Compoundλa
(nm)
tRb
(min)
RSDc
(%)
Linear Range
(μg/mL)
Regression Equationdr2 eLOD
(μg/mL)
LOQ
(μg/mL)
berberine23020.200.262.50–25.00Y = 59,041.58 x + 7174.760.99980.1310.398
palmatine23021.070.252.50–25.00Y = 44,562.64 x + 7204.290.99990.1790.543
geniposide24022.260.395.00–50.00Y = 23,807.44 x + 6159.40.99980.2170.659
paeoniflorin23024.110.385.00–50.00Y = 19,555.98 x − 2874.870.99940.2960.898
a Detection wavelength; b Retention times; c Relative standard deviation; d Y: peak area, x: concentration (μg/mL).; e Coefficient of determination.
Table 2. Precision and accuracy of the HPLC–PDA method for the four compounds.
Table 2. Precision and accuracy of the HPLC–PDA method for the four compounds.
CompoundConc.
(μg/mL)
Intra-Day (n = 3)Inter-Day (n = 3)
Measured Conc.
(μg/mL)
RSD
(%)
Accuracy
(%)
Measured
Conc.
(μg/mL)
RSD
(%)
Accuracy
(%)
berberine3.913.922.348102.533.852.281100.45
5.215.020.69798.285.041.06898.70
7.817.680.111100.367.680.946100.38
palmatine3.913.902.127101.793.862.840100.83
5.214.990.82697.715.011.77498.22
7.817.691.230100.487.691.109100.49
geniposide7.817.781.135101.637.681.467100.34
10.429.880.28096.7410.001.06197.95
15.6315.501.526101.2215.411.118100.64
paeoniflorin7.817.811.693101.967.643.59399.76
10.4210.031.73198.2310.091.27498.85
15.6315.302.85799.9115.382.444100.42
Table 3. Recoveries of the four compounds in Haedoksamul-tang (HST) samples (n = 3).
Table 3. Recoveries of the four compounds in Haedoksamul-tang (HST) samples (n = 3).
CompoundSpiked Amount
(μg/mL)
Found Amount
(μg/mL)
Recovery
(%)
SDRSD
(%)
Berberine2.6058.3392.970.0323.486
5.2159.8890.520.0131.404
7.8172.74108.460.0403.693
palmatine2.6031.0698.970.0333.365
5.2131.9492.330.0434.705
7.8140.25113.130.0332.881
geniposide5.21319.60104.350.0090.893
10.42326.28104.710.0121.099
15.63367.28116.720.0090.731
paeoniflorin5.21141.2195.420.0404.148
10.42151.0498.050.0151.571
15.63178.61114.410.0342.955
Table 4. Amounts of the four compounds in HST (n = 4).
Table 4. Amounts of the four compounds in HST (n = 4).
CompoundMean (mg/g)SDRSD (%)
berberine2.110.0180.854
palmatine1.540.0332.141
geniposide10.770.2492.313
paeoniflorin7.040.1171.667

Share and Cite

MDPI and ACS Style

Jo, B.-G.; Kang, K.-H.; Yang, M.H. Development and Validation of a HPLC–PDA Method for the Simultaneous Determination of Berberine, Palmatine, Geniposide, and Paeoniflorin in Haedoksamul-tang. Appl. Sci. 2020, 10, 5482. https://doi.org/10.3390/app10165482

AMA Style

Jo B-G, Kang K-H, Yang MH. Development and Validation of a HPLC–PDA Method for the Simultaneous Determination of Berberine, Palmatine, Geniposide, and Paeoniflorin in Haedoksamul-tang. Applied Sciences. 2020; 10(16):5482. https://doi.org/10.3390/app10165482

Chicago/Turabian Style

Jo, Beom-Geun, Kyung-Hwa Kang, and Min Hye Yang. 2020. "Development and Validation of a HPLC–PDA Method for the Simultaneous Determination of Berberine, Palmatine, Geniposide, and Paeoniflorin in Haedoksamul-tang" Applied Sciences 10, no. 16: 5482. https://doi.org/10.3390/app10165482

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop